Thesis Abstract

Abstract
Cancer remains a significant global health challenge, necessitating the continuous development of innovative therapeutic approaches. This thesis explores the development of novel drug delivery systems for targeted cancer therapy, aiming to enhance treatment efficacy while minimizing adverse effects. The study focuses on leveraging advanced nanotechnology and biomaterials to design and optimize drug delivery platforms that can selectively target cancer cells, improving drug delivery efficiency and reducing systemic toxicity. The introduction provides a comprehensive overview of the background of the study, highlighting the current limitations in conventional cancer therapies and the need for targeted drug delivery systems. The problem statement underscores the challenges in achieving effective cancer treatment with minimal side effects, emphasizing the importance of developing precision medicine approaches. The objectives of the study are outlined to guide the research towards designing innovative drug delivery systems that can enhance therapeutic outcomes in cancer patients. The literature review delves into ten key areas, exploring existing research on nanomedicine, biomaterials, targeted drug delivery, cancer biology, and therapeutic strategies. By analyzing the current state of the field, gaps in knowledge are identified, providing a foundation for the research methodology. The research methodology section outlines the experimental design, materials used, data collection methods, and analytical techniques employed in the study. Key components include the synthesis of nanoparticles, in vitro and in vivo testing, and characterization of drug release profiles. Chapter four presents a detailed discussion of the findings, highlighting the efficacy of the novel drug delivery systems in targeting cancer cells and evaluating their therapeutic potential. Results from cell culture studies and animal models are analyzed, demonstrating the enhanced anti-cancer effects of the developed drug delivery platforms. Factors influencing drug release kinetics, cellular uptake, and cytotoxicity are investigated to optimize the system for clinical translation. In conclusion, the study underscores the significance of developing targeted drug delivery systems for improving cancer therapy outcomes. The novel platforms offer promising potential for enhancing treatment efficacy, reducing side effects, and overcoming drug resistance mechanisms in cancer. The thesis contributes valuable insights to the field of precision medicine and nanomedicine, paving the way for the development of personalized cancer therapies that can revolutionize patient care. Keywords Cancer therapy, drug delivery systems, nanomedicine, targeted therapy, biomaterials, precision medicine, nanotechnology, anti-cancer efficacy.

Thesis Overview